[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"telemonitoring\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:telemonitoring":118},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,47,70,97],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":30,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":46},"100619508",false,"NCT07345533","EXPLORATORY STUDY OF THE MYHEARTSENTINEL SYSTEM, A CARDIAMETRICS MEDICAL DEVICE","EXPLORATORY STUDY OF THE MYHEARTSENTINEL SYSTEM, A CARDIAMETRICS MEDICAL DEVICE - ANALYSIS OF CARDIAC ELECTROPHYSIOLOGICAL AND MECHANICAL SIGNALS DURING A DECOMPENSATION\u002FRECOMPENSATION EPISODE IN PATIENTS WITH HEART FAILURE IN THE HOSPITAL AND UPON DISCHARGE HOME","ASEMC-DR","Inclusion Criteria:\n\n* Patients aged between 18 and 90 years\n* Affiliated with the social security system.\n* Patients who have been informed of the study and have signed informed consent.\n* Patients with heart failure and one of the following two criteria:\n\n  * Hospitalized for hemodynamic assessment\n  * Hospitalized in a cardiology unit (ICU or telemetry unit) for congestive decompensation of known heart failure defined by \\[8\\] minimal dyspnea at rest or during exercise AND an elevation of BNP \\> 400 µg\u002Fml or NT-proBNP \\> 1600 µg\u002Fml\n\nExclusion Criteria:\n\n* Patient hospitalized for decompensated heart failure due to an infectious cause requiring antibiotic treatment\n* Patient requiring intravenous inotropes within the last 24 hours\n* Patient with ventricular arrhythmias or permanent AF\n* ACS with ST+ complex complicated by heart failure\n* Valvulopathy awaiting interventional management\n* Pericardial constriction\n* Pregnant or breastfeeding women\n* Women of childbearing potential without effective contraception\n* Patients under guardianship, curatorship, legal protection, or legal protection.\n* Patients already enrolled in an interventional clinical trial that may impact the electrophysiological and cardiac mechanical measurements of the medical device under study. • Inability to position the sensor on the thoracic area of interest\n* Patients with open wounds, recent scars, or skin infections at the intended SCOUT device placement site\n* Patients suffering from dermatitis, eczema, psoriasis, or other skin conditions at the placement site.\n* Physical or psychological inability of the patient or caregiver to use the digital medical telemonitoring device and\u002For its collection accessories, as determined by the physician wishing to include the patient in the medical telemonitoring project;\n* Patient refusal to transmit the data necessary to monitor the effective use of the DMN and to obtain individualized or national real-life usage results;\n* Patient refusal to receive therapeutic support.","ALL","18 Years","90 Years",{"count":20,"type":21},70,"ESTIMATED","INTERVENTIONAL",[24],"NA","Background:\n\nChronic heart failure represents a major public health challenge, affecting approximately 64 million people worldwide and generating high costs in terms of mortality, frequent hospitalizations, and medical expenses. In France, this disease is expected to cause nearly 70,000 deaths and 181,000 hospital admissions in 2022. Current management, based on periodic consultations, fails to effectively prevent acute exacerbations, highlighting the importance of technological solutions such as remote monitoring.\n\nObjective:\n\nThis study aims to demonstrate the value of regular monitoring of electrophysiological and mechanical cardiac signals and parameters in patients with chronic heart failure. Its goal is to build a database of signals from an external measuring device (MyHeartSentinel MHS) to identify parameters that evolve in relation to biological and\u002For hemodynamic changes and\u002For the patient's clinical status. The results of this study will enable the further development of an automated monitoring solution for heart failure patients to enable early detection and management of decompensation.\n\nMaterials and Methods:\n\nA total of 70 patients diagnosed with chronic heart failure will be included, including 30 patients hospitalized for heart failure decompensation and 40 patients hospitalized for hemodynamic assessment. Electrophysiological and cardiac mechanical data will be collected using a skin-based measuring device. These data will then be correlated with biological and\u002For hemodynamic changes and\u002For the patient's clinical status. They will contribute to the training of an algorithm to detect the risk of decompensation.\n\nHypothesis Tested:\n\nAbility of MHS to detect electrophysiological and cardiac mechanical data related to cardiac decompensation, such as cardiac filling pressure.",[27,28,29],"Heart Failure","Telemonitoring","Right Heart Catheterisation",[28,31,32,33],"heart failure","right heart catheterisation","acute heart failure","RECRUITING","2026-06-24",{"date":37,"type":38},"2026-06-26","ACTUAL",{"date":40,"type":38},"2025-07-17",{"date":42,"type":21},"2028-03-17",{"name":44,"class":45},"University Hospital, Caen","OTHER",1,{"id":48,"slug":4,"hasResults":10,"nctId":49,"briefTitle":50,"officialTitle":50,"acronym":51,"eligibilityCriteria":52,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":53,"targetDuration":4,"studyType":55,"phases":4,"briefSummary":56,"conditions":57,"keywords":58,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":69},"100607298","NCT07186738","Study of a Patient Cohort Following Digestive Surgical Care After the Implementation of a Telemonitoring and Tele-coordination Platform for Medical, Paramedical, and Social Management","EPOCA","Inclusion Criteria:\n\n* Male or female patients over 18 years of age.\n* Patients undergoing colorectal or bariatric surgery not routinely managed as outpatient procedures at Nantes University Hospital.\n* At least one of the following criteria:\n* Anticipated early discharge (within 24 hours post-surgery) for procedures not routinely managed as outpatient at the hospital.\n* Estimated risk of readmission greater than 6% according to the Tevis et al. nomogram, adapted to the postoperative context in digestive surgery (\\>50 points on this score).\n* Patients enrolled in a health insurance plan\n\nExclusion Criteria:\n\n* Discharge to a rehabilitation center requested by the patient\n* Condition routinely managed as an outpatient procedure\n* Patient under home hospitalization care\n* Suicidal or heteroaggressive risk in a patient living alone at home\n* Homeless patients\n* Pregnant or breastfeeding women\n* Patients under legal guardianship, conservatorship, or judicial protection",{"count":54,"type":21},250,"OBSERVATIONAL","Postoperative hospital stays and complications vary widely after digestive surgery. Enhanced Recovery After Surgery (ERAS) protocols have shortened stays and accelerated recovery after elective procedures, but they remain challenging in emergency surgery and among frail or elderly patients. While theoretical discharge after colorectal surgery is possible between postoperative days 2 and 7, average stays in practice are 12-14 days. Bariatric surgery similarly targets discharge on days 2-3, yet typical stays are 8-10 days. Patients successfully managed under ERAS may face higher readmission risk, often due to worsening comorbidities or serious complications.\n\nProlonged hospitalization and readmissions impact patient safety, comfort, and healthcare costs. Daily hospital costs in surgical units range from €350 to €400. Post-acute care facilities can reduce readmissions but often have long waiting periods. To minimize readmission risk, many surgeons prefer in-hospital postoperative monitoring, limiting early discharge.\n\nRecent studies show that connected devices and teleconsultation can provide safe and effective postoperative follow-up. Teleconsultation follow-up is feasible for most patients, with satisfaction rates comparable to in-person visits. Remote monitoring of stoma care has been associated with reduced readmissions. Home-based monitoring using connected vital sign devices in high-risk patients reduces readmissions and emergency visits. In colorectal and bariatric surgery, daily remote monitoring after early discharge (24-48 hours) did not increase morbidity or readmission, suggesting that telemonitoring can safely enable earlier discharge while maintaining patient safety. Continuous monitoring is particularly important for high-risk patients due to rapid deterioration from potential complications.\n\nEPOCA is a telemonitoring and telecoordination platform providing medical, paramedical, and social follow-up at home. It combines connected devices, a digital platform for data analysis, and a dedicated medical and paramedical team. Services include teleconsultations, home paramedical care, support for families or care facilities, and 24\u002F7 emergency management.\n\nEPOCA reassures patients and caregivers, supports primary care and home care teams, and integrates hospital and emergency services. It addresses challenges posed by aging populations, chronic disease prevalence, and increasingly complex patients. By enabling earlier discharge without increasing readmissions, EPOCA offers a holistic solution bridging hospital and home care. It has already demonstrated success in preventing hospitalizations in high-risk elderly patients and is authorized for telemonitoring of chronic conditions including diabetes, respiratory, renal, and cardiac insufficiency.\n\nThis study aims to evaluate the feasibility of implementing EPOCA over two years in the CHU Nantes digestive surgery unit. It will target patients undergoing elective or urgent colorectal or bariatric surgery who are at risk of prolonged hospitalization or readmission. High-risk scenarios include anticipated early discharge within 24 hours and patients identified as having elevated readmission risk according to predefined criteria",[28],[59,60],"telemonitoring","digestive surgery","2026-06-23",{"date":35,"type":38},{"date":64,"type":38},"2025-10-01",{"date":66,"type":21},"2027-10-01",{"name":68,"class":45},"Nantes University Hospital",2,{"id":71,"slug":4,"hasResults":10,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":4,"eligibilityCriteria":75,"healthyVolunteers":76,"sex":77,"minAge":17,"maxAge":4,"enrollmentInfo":78,"targetDuration":4,"studyType":22,"phases":80,"briefSummary":81,"conditions":82,"keywords":4,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":87,"lastUpdatePostDateStruct":88,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":46},"100602501","NCT07124325","Remote Cardiotocography Telemonitoring Within High-risk Pregnancy Care","The Use of Remote Cardiotocography Telemonitoring Within High-risk Pregnancy Care.","Inclusion Criteria:\n\n* Women aged ≥18 years\n* Gestational age 32+0 weeks onwards.\n* Singleton pregnancy.\n* Able to speak English\n* Receiving antenatal care which includes routine antenatal fetal monitoring for one of the 6 index conditions (hypertensive disease in pregnancy, reduced fetal growth (small for gestational age and fetal growth restriction) obstetric cholestasis, PPROM, previous history of stillbirth and recurrent reduced fetal movements )\n* Able to give written informed consent.\n* Willing to attend hospital immediately in the event of an unexpected finding whilst using the home devices.\n\nExclusion Criteria:\n\n* Multiple pregnancy.\n* Fetal abnormalities or a non-viable fetus.\n* Body mass index (BMI) ≥35\n* Women with internal cardiac devices such as pacemaker and implantable cardioverter defibrillator.\n* History of allergic reaction to skin adhesives and\u002For latex.\n* Acute or chronic skin lesions and wounds in areas in contact with the device.",true,"FEMALE",{"count":79,"type":21},50,[24],"The overall aim of this research proposal is to explore the feasibility and acceptability of home antenatal maternal-fetal monitoring technology within a high-risk pregnancy group. The investigators hypothesise that home monitoring is feasible and acceptable to both pregnant women and HCPs.\n\n50 women from a single site will be recruited to use a home cardiotocography (CTG) device alongside routine antenatal care. Participants will use this device once a week, for an hour at a time, for up to 6 weeks or until delivery. The primary outcome is 20 minutes of continuous monitoring. Additional outcomes assess acceptability, adherence and safety.",[83,84,28,85,86],"Pregnancy","High Risk","Telemedicine","Cardiotocography","2025-08-08",{"date":89,"type":38},"2025-08-15",{"date":91,"type":38},"2025-06-11",{"date":93,"type":21},"2026-04-01",{"name":95,"class":96},"Birmingham Women's NHS Foundation Trust","OTHER_GOV",{"id":98,"slug":4,"hasResults":10,"nctId":99,"briefTitle":100,"officialTitle":100,"acronym":101,"eligibilityCriteria":102,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":103,"targetDuration":4,"studyType":22,"phases":105,"briefSummary":106,"conditions":107,"keywords":4,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":110,"startDateStruct":112,"completionDateStruct":114,"leadSponsor":116,"locationsCount":46},"100594639","NCT07022067","EVOLVING AZIMUTH IN MUSA CONTEXT","AZIMUSA","Inclusion Criteria:\n\n* Have been diagnosed with chronic CS according to the ESC guidelines;\n* Over 18 years of age;\n* Patients admitted to hospital or with access to first aid within the last year;\n* Smartphome that meets the digital requirements (ie Android or iOS able to download and use the application);\n* Wi-Fi or 3G coverage at home;\n* Ability to give written informed consent.\n\nExclusion Criteria:\n\n* Severe psychiatric disorder\n* Inability to use portable technologies\n* Patients unable to use the equipment provided\n* Patients who deny consent to study participation",{"count":104,"type":21},184,[24],"Non-pharmacological, randomized, nonprofit medical device intervention. The study aims to identify the positive impacts (co-creation), and negative impacts (co-destruction), resulting from the use of telemedicine, and, in particular, the telemonitoring service for patients with heart failure",[27,108,109,28],"Blood Pressure","Weight Change",{"date":111,"type":38},"2025-06-15",{"date":113,"type":38},"2024-10-02",{"date":115,"type":21},"2025-08-31",{"name":117,"class":45},"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico",""]